163 related articles for article (PubMed ID: 1471215)
41. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
Ito S; Tateno C; Tuda M; Yoshitake A
Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
[TBL] [Abstract][Full Text] [Related]
42. Effects of low dose mixtures of four N-nitroso compounds on hepatic foci development in the rat.
Futakuchi M; Lijinsky W; Hasegawa R; Hirose M; Ito N; Shirai T
Cancer Lett; 1996 Sep; 106(2):263-9. PubMed ID: 8844982
[TBL] [Abstract][Full Text] [Related]
43. c-Jun expression in single cells and preneoplastic foci induced by diethylnitrosamine in B6C3F1 mice: comparison with the expression of pi-class glutathione S-transferase.
Nakano H; Hatayama I; Satoh K; Suzuki S; Sato K; Tsuchida S
Carcinogenesis; 1994 Sep; 15(9):1853-7. PubMed ID: 7923577
[TBL] [Abstract][Full Text] [Related]
44. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats.
Tiwawech D; Hasegawa R; Kurata Y; Tatematsu M; Shibata MA; Thamavit W; Ito N
Carcinogenesis; 1991 Jun; 12(6):985-90. PubMed ID: 2044205
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte growth factor enhancement of preneoplastic hepatic foci development in rats treated with diethylnitrosamine and N-ethyl-N-hydroxyethylnitrosamine.
Yaono M; Hasegawa R; Mizoguchi Y; Futakuchi M; Nakamura T; Ito N; Shirai T
Jpn J Cancer Res; 1995 Aug; 86(8):718-23. PubMed ID: 7559093
[TBL] [Abstract][Full Text] [Related]
46. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization.
Imai T; Masui T; Ichinose M; Nakanishi H; Yanai T; Masegi T; Muramatsu M; Tatematsu M
Carcinogenesis; 1997 Mar; 18(3):545-51. PubMed ID: 9067555
[TBL] [Abstract][Full Text] [Related]
47. Effects of pinocembrin on the initiation and promotion stages of rat hepatocarcinogenesis.
Punvittayagul C; Pompimon W; Wanibuchi H; Fukushima S; Wongpoomchai R
Asian Pac J Cancer Prev; 2012; 13(5):2257-61. PubMed ID: 22901204
[TBL] [Abstract][Full Text] [Related]
48. Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers.
Yokoyama Y; Tsuchida S; Hatayama I; Satoh K; Narita T; Rao MS; Reddy JK; Yamada J; Suga T; Sato K
Carcinogenesis; 1992 Feb; 13(2):265-9. PubMed ID: 1740018
[TBL] [Abstract][Full Text] [Related]
49. Reappraisal of eight representative carcinogenic and non-carcinogenic compounds in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Cha SW; Ha CS; Roh JK; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1996 Jun; 104(1):85-90. PubMed ID: 8640751
[TBL] [Abstract][Full Text] [Related]
50. S-methylcysteine and cysteine are inhibitors of induction of glutathione S-transferase placental form-positive foci during initiation and promotion phases of rat hepatocarcinogenesis.
Takada N; Yano Y; Wanibuchi H; Otani S; Fukushima S
Jpn J Cancer Res; 1997 May; 88(5):435-42. PubMed ID: 9247599
[TBL] [Abstract][Full Text] [Related]
51. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats.
Fukushima S; Hagiwara A; Hirose M; Yamaguchi S; Tiwawech D; Ito N
Jpn J Cancer Res; 1991 Jun; 82(6):642-9. PubMed ID: 1906850
[TBL] [Abstract][Full Text] [Related]
52. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen.
Kassie F; Uhl M; Rabot S; Grasl-Kraupp B; Verkerk R; Kundi M; Chabicovsky M; Schulte-Hermann R; Knasmüller S
Carcinogenesis; 2003 Feb; 24(2):255-61. PubMed ID: 12584175
[TBL] [Abstract][Full Text] [Related]
53. Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes.
Kudo T; Asano J; Shimizu T; Nanashima N; Fan Y; Akita M; Ookawa K; Hayakari M; Yokoyama Y; Suto K; Tsuchida S
Cancer Sci; 2006 Aug; 97(8):703-9. PubMed ID: 16800819
[TBL] [Abstract][Full Text] [Related]
54. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
[TBL] [Abstract][Full Text] [Related]
55. Carcinogenicity of methylurea or morpholine in combination with sodium nitrite in rat multi-organ carcinogenesis bioassay.
Kitano M; Takada N; Chen T; Ito H; Nomura T; Tsuda H; Wild CP; Fukushima S
Jpn J Cancer Res; 1997 Sep; 88(9):797-806. PubMed ID: 9369926
[TBL] [Abstract][Full Text] [Related]
56. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
[TBL] [Abstract][Full Text] [Related]
57. A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals.
Tsuda H; Futakuchi M; Fukamachi K; Shirai T; Imaida K; Fukushima S; Tatematsu M; Furukawa F; Tamano S; Ito N
Toxicol Pathol; 2010 Jan; 38(1):182-7. PubMed ID: 20080933
[TBL] [Abstract][Full Text] [Related]
58. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
[TBL] [Abstract][Full Text] [Related]
59. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
[TBL] [Abstract][Full Text] [Related]
60. Marriage of a medium-term liver model to surrogate markers--a practical approach for risk and benefit assessment.
Moore MA; Tsuda H; Tamano S; Hagiwara A; Imaida K; Shirai T; Ito N
Toxicol Pathol; 1999; 27(2):237-42. PubMed ID: 10207988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
